March 1, 2009 -- Our Executive Editor, Greg Scott, answers questions about the state of China biotech in interviews conducted by CCTV in Beijing, and Windhover Information in the US. He discusses the size of China biopharma, recent changes, new policy initiatives, outsourcing and he looks forward to predict the trends coming in the future. More details...
